Desmond Bane
26-27 Projection
FT%: league rank #11, top 20 in the league.
ORL
Value
+6.77
League Leader33.5
This Player20.1
League Average11.0
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 20-21 | #223 |
| 21-22 | #43 |
| 22-23 | #31 |
| 23-24 | #35 |
| 24-25 | #29 |
| 25-26 | #34 |
| 26-27 Projection | #21 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 20-21 | 9.2 |
| 21-22 | 18.2 |
| 22-23 | 21.5 |
| 23-24 | 23.7 |
| 24-25 | 19.2 |
| 25-26 | 20.1 |
| 26-27 Projection | 20.2 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)NBA playoffs (aggregate — not in averages or ranks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 16.2 |
| Nov 2025 | 19.2 |
| Dec 2025 | 20.2 |
| Jan 2026 | 19.8 |
| Feb 2026 | 24.7 |
| Mar 2026 | 20.4 |
| Apr 2026 | 17.3 |
| Playoffs (playoffs) | 18.1 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
ORL — all five positions, best player first at each spot.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 29 | ORL | 70 | 0 | 33.6 | #21 | 6.77 | 20.2 | 4.7 | 4.5 | 1.1 | 0.5 | 2.3 | 48.0% | 15.2 | 90.0% | 3.8 | 2.1 |
| 25-26 | 28 | ORL | 82 | 0 | 33.6 | #34 | 5.61 | 20.1 | 4.1 | 4.1 | 1 | 0.5 | 2 | 48.4% | 14.7 | 90.8% | 4.2 | 2 |
| 24-25 | 27 | ORL | 69 | 0 | 32 | #29 | 6.43 | 19.2 | 6.1 | 5.3 | 1.2 | 0.4 | 2.4 | 48.4% | 14.8 | 89.4% | 2.9 | 2.4 |
| 23-24 | 26 | MEM | 42 | 0 | 34.4 | #35 | 6.25 | 23.7 | 4.4 | 5.5 | 1 | 0.5 | 3.3 | 46.4% | 18.5 | 87.0% | 3.8 | 2.7 |
| 22-23 | 25 | MEM | 58 | 0 | 31.7 | #31 | 6.11 | 21.5 | 5 | 4.4 | 1 | 0.4 | 2.9 | 47.9% | 16.2 | 88.3% | 3.5 | 2.2 |
| 21-22 | 24 | MEM | 76 | 0 | 29.8 | #43 | 5.78 | 18.2 | 4.4 | 2.7 | 1.2 | 0.4 | 3 | 46.1% | 14.5 | 90.3% | 2 | 1.5 |
| 20-21 | 23 | MEM | 68 | 0 | 22.3 | #223 | -0.99 | 9.2 | 3.1 | 1.7 | 0.6 | 0.2 | 1.7 | 46.9% | 7.3 | 81.6% | 0.7 | 0.9 |